Skip to main content
Equibles
LLY logo

LLY · ELI LILLY & Co · Metrics

Track LLY — free

Use LLY with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LLY.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1,280.00 +39.66 (+3.20%)
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$1.17T
Shares
941.36M
Volume · Oct 20 2.99M Avg daily vol (3M) 2.47M

LLY metrics

96 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1,283.66
Market cap
$1.17T

Price action

20 metrics
Price change (1W)
+4.9%
Price change (30D)
+6.5%
Price change (3M)
+8.1%
Price change (6M)
+34.8%
Price change (YTD)
+15.4%
Price change (1Y)
+54.5%
Trailing year
Price change (5Y)
+411.9%
52-week high
$1,280.34
52-week low
$799.57
Change from 52-week high
-3.1%
Change from 52-week low
+55.1%
Annualized volatility
34.8%
Annualized volatility (3M)
29.9%
Beta
0.3
RSI (14D)
63.4
Price vs SMA 50
+5.0%
Price vs SMA 200
+14.8%
Avg volume (3M)
2.47M
Relative volume
0.8
Average dollar volume
$2.91B

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - General
Shares outstanding
941.36M

Valuation

12 metrics
P / E (TTM)
41.6
Trailing earnings · reciprocal yield 2.4%
PEG ratio
1.6
EV / revenue
15.4×
reciprocal yield 6.5%
EV / EBITDA
—
EV / EBIT
—
P / sales
14.9×
reciprocal yield 6.7%
P / book
34.9
reciprocal yield 2.9%
FCF yield
—
TTM · current market cap
Buyback yield
0.5%
P / FCF
—
P / operating cash flow
42.1
reciprocal yield 2.4%
Earnings yield
2.3%

Historical valuation

8 metrics
P / E historical average (3Y)
73.6×
reciprocal yield 1.4%
P / E historical average (5Y)
64.4×
reciprocal yield 1.6%
EV / revenue historical average (3Y)
17.2×
reciprocal yield 5.8%
EV / revenue historical average (5Y)
14.9×
reciprocal yield 6.7%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
0.5%
Trailing 12 months
Payout ratio
21.7%
Shareholder yield
1.0%
Dividend / share (TTM)
$6.69
Dividend growth YoY
+15.3%
Dividend growth streak
5+
Stored dividend history starts 2020
Last ex-dividend
2026-08-14

Earnings calendar

2 metrics
Next earnings
2026-10-29
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
83.4%
Operating margin
—
Trailing 12 months
Net margin
33.5%
Gross profit (TTM)
$66.44B
Operating profit (TTM)
—
Net income (TTM)
$26.71B
Trailing 12 months
Diluted EPS (TTM)
$29.80
FCF margin
—
Effective tax rate
20.5%

Per share

11 metrics
Revenue per diluted share (TTM)
$88.87
Gross profit per diluted share (TTM)
$74.12
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$29.80
Operating cash flow per diluted share (TTM)
$31.34
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$16.28
Stock compensation per diluted share (TTM)
$0.72
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+47.7%
Year over year
Net income growth YoY
+25.3%
Revenue (TTM)
$79.67B
Trailing 12 months
EPS growth YoY
+26.2%
Shares change YoY
-0.7%
Year over year · fewer shares
Revenue CAGR (3Y)
+31.7%
Revenue CAGR (5Y)
+21.6%
EPS CAGR (3Y)
+49.3%
EPS CAGR (5Y)
+27.6%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
78.8%
Return on assets
18.8%
Debt / equity
1.6
Current ratio
1.4
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
1.0
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$45.96B
Latest balance sheet
Cash & equivalents
$8.95B
Total assets
$142.28B
Total debt
$54.91B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$28.08B
Capital expenditures (TTM)
—
R&D (TTM)
$14.60B
SG&A (TTM)
$12.24B
Stock compensation (TTM)
$649.00M
R&D / revenue
18.3%
Stock compensation / revenue
0.8%

Ownership (13F)

9 metrics
13F filers
4,664
13F filer change QoQ
+263
Institutional ownership
86.8%
Conviction holders (share of 13F filers)
12.4%
Crowding (high-turnover and private-fund holders)
7.3%
Private-fund adviser ownership
7.0%
Active holders' share change QoQ
-0.3%
Holder tenure
20.4
Price vs estimated holder cost
+62.8%

Ownership (registered funds)

1 metrics
Index-fund ownership
15.0%

Short interest

3 metrics
Short interest
0.7%
Latest settlement · 2.9 days to cover
Days to cover
2.9d
Short-squeeze score
61 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$15.96M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 59478 CUSIP 532457108 13F (30d) 1007 filings 975 filers Visit website Investor relations